![]() |
市場調查報告書
商品編碼
1396585
臨床資料管理系統 (CDMS) 市場 - 按交付模式(許可企業解決方案、基於雲端的解決方案)、最終用途(合約研究組織、醫療器材公司)、全球預測(2023 年 - 2032 年)Clinical Data Management Systems (CDMS) Market - By Delivery Mode (Licensed Enterprise Solutions, Cloud-based Solutions), By End-use (Contract Research Organizations, Medical Device Companies), Global Forecast (2023 - 2032) |
由於醫療保健資料數位化程度不斷提高以及對資料安全性和合規性的日益重視,臨床資料管理系統 (CDMS) 市場規模從 2023 年到 2032 年的CAGR預計將達到 11.2%。根據美國醫學協會 (AMA) 2022 年數位醫療保健研究結果,選擇數位醫療工具進行病患照護的醫生數量從 2016 年的 85% 成長到 2022 年的 93%。
CDMS 解決方案的需求量很大,因為它們有助於優先考慮資料加密、存取控制以及遵守資料保護法規。在醫療保健和生命科學領域,這些解決方案有助於減輕與資料外洩和網路攻擊相關的風險。增加與強大的安全功能(包括審計追蹤和監控功能)的整合也將決定市場的成長。
整個 CDMS 產業分為交付模式、最終用途和區域。
在交付模式方面,從2023年到2032年,授權企業(本地)解決方案領域的市場佔有率將以超過10%的CAGR擴大。這可以歸因於人們越來越偏好本地 CDMS 解決方案,因為它們為組織提供了對資料安全性和合規性的更大控制。這些解決方案還提供整個軟體環境的高水準客製化和控制。具有大型資料集和特定效能要求的組織也會選擇本地 CDMS 技術來確保最佳化效能。
基於最終用途,由於簡化和管理收集、分析和報告臨床試驗資料的複雜流程的需求激增,醫療器材公司細分市場的臨床資料管理系統產業價值從 2023 年到 2032 年可能會成長 9.6% 。 CDMS 憑藉其電子資料擷取 (EDC) 功能,有助於簡化資料收集過程。即時資料輸入、減少對紙本方法的依賴以及最大限度地降低資料轉錄錯誤的風險等優勢也將促進該細分市場的成長。
從地區來看,預計到 2032 年,亞太地區 CDMS 市場規模的CAGR將達到 13.2%,原因是行動和穿戴式技術的不斷融合,以確保即時資料採集、患者參與和監測,以實現更多以病人為中心的臨床試驗。隨著醫療保健資料數位化的不斷發展,對資料安全性和監管要求合規性的重視顯著提高。資料管理實踐標準化的不斷努力將推動區域產業擴張。
Clinical Data Management Systems (CDMS) Market size is poised to record 11.2% CAGR from 2023-2032, on account of the increasing digitization of healthcare data and the heightened emphasis on data security and compliance. As per the American Medical Association (AMA) digital health care 2022 study findings, the number of physicians opting for digital health tools for patient care grew from 85% in 2016 to 93% in 2022.
CDMS solutions are witnessing significant demand as they help to prioritize data encryption as well as access controls and compliance with data protection regulations. In healthcare and life sciences sectors, these solutions help mitigate the risks associated with data breaches and cyberattacks. Increasing integration with robust security features, including audit trails and monitoring capabilities will also define the market growth.
The overall CDMS industry is segmented into delivery mode, end-use, and region.
In terms of delivery mode, the market share from the licensed enterprise (on-premise) solutions segment will expand at over 10% CAGR from 2023-2032. This can be attributed to the growing preference for on-premise CDMS solutions as they offer greater control to organizations over data security and compliance. These solutions also provide high level of customization and control throughout the software environment. Organizations with large datasets and specific performance requirements also opt for on-premise CDMS technology to ensure optimized performance.
Based on end-use, the clinical data management systems industry value from the medical device companies segment may witness 9.6% growth rate from 2023-2032 driven by the surging need to streamline and manage complex processes of collecting, analyzing, and reporting clinical trial data. CDMS helps simplify the process of data collection on account of its electronic data capture (EDC) capabilities. Advantages, such as real-time data entry, reduced reliance on paper-based methods and minimized risk of data transcription errors will also boost the segment growth.
Regionally, the Asia Pacific CDMS market size is projected to record 13.2% CAGR through 2032 owing to the rising integration of mobile and wearable technologies to ensure real-time data capture, engagement patient and monitoring for more patient-centric clinical trials. With increasing digitization of healthcare data, the emphasis on data security and compliance with regulatory requirements has significantly heightened. The increasing efforts led towards standardization of data management practices will push the regional industry expansion.